Functional Neurosurgery and Anesthetic Considerations - PowerPoint PPT Presentation

1 / 58
About This Presentation
Title:

Functional Neurosurgery and Anesthetic Considerations

Description:

or restore function by altering underlying physiology' Areas of Functional Neurosurgery ... 80% afferent: extensive connections to limbic and higher cortical systems ... – PowerPoint PPT presentation

Number of Views:1289
Avg rating:3.0/5.0
Slides: 59
Provided by: anesthe2
Category:

less

Transcript and Presenter's Notes

Title: Functional Neurosurgery and Anesthetic Considerations


1
Functional Neurosurgery and Anesthetic
Considerations
  • Susan M Ryan, PhD, MD
  • Associate Clinical Professor
  • Department of Anesthesia, UCSF
  • 2006

2
What is Functional Neurosurgery?
  • Neurosurgery intended to improve
  • or restore function by altering underlying
    physiology

3
Areas of Functional Neurosurgery
  • Movement disorders
  • Seizures
  • Pain syndromes
  • Psychiatric disorders
  • Peripheral nerve injuries

4
Areas of Expansion
  • Movement disorders
  • Seizures
  • Psychiatric disorders

5
Neurosurgical Techniques
  • Deep brain stimulation (DBS)
  • Selective ablation
  • electrodes
  • Implantation
  • viral vectors
  • stem cells
  • Cranial nerve/ peripheral electrical stimulation

6
Functional Neurosurgery
  • Began in mid-1900s
  • Eclipsed by effective medications
  • Now Non-responders
  • Advanced cases

7
Neurosurgical Techniques
  • Deep brain stimulation
  • Best established use
  • Parkinsons Disease
  • Vagal nerve stimulation
  • Best established use
  • Seizure disorders

8
DBS/VNS Studies in Progress
  • Obesity
  • Fibromyalgia
  • Cluster headache
  • Tourettes Syndrome
  • Depression
  • Obsessive Compulsive Disorder

9
  • DBS for Parkinsons Disease

10
Clinical Features
  • Pill-rolling tremor
  • Masked faces
  • Cog-wheel rigidity
  • Festinating gate
  • Bradykinesia

11
Pathologic Features
  • Progressive neuronal death
  • Dopamine neurons of substantia nigra
  • Non- dopamine populations in CNS and PNS
  • Bulbar function
  • Sympathetic chain
  • Parasympathetics of the gut

12
Basal Ganglia in PD
13
(No Transcript)
14
Treatment
  • Medications
  • L-dopa periph. inhibitor (Sinamet)
  • Dopamine agonists
  • MAO inhibitors
  • COMT inhibitors
  • Amantadine

15
DBS Surgery
  • Goal Improvement in PD symptoms
  • Tremor
  • Rigidity
  • Hypokinesia
  • Gait
  • Balance

16
(No Transcript)
17
DBS Surgery
  • Placement of stereotactic frame prior to
    procedure
  • MRI to confirm coordinates

18
DBS Surgery
  • Stereotactic head frame attached to bed
  • Pt placed in sitting position

19
DBS Stereotactic Surgery
  • Drill hole in skull to allow electrode placement
    for recording stimulation

20
DBS Stereotactic Surgery
  • Electrode passed slowly to record single cells in
    nucleus of interest

21
DBS Stereotactic Surgery
  • Visual and auditory feedback of cell location and
    characteristics

22
DBS Stereotactic Surgery
  • Listening for cell response during leg movement

23
DBS Surgery
  • Find best location within the nucleus
  • Place stimulating electrode
  • Close burr hole, remove frame
  • Induce general anesthesia
  • Tunnel leads
  • Place generator in upper chest wall
  • Wait to activate stimulator in outpatient setting

24
Anesthesia DBS Generator placement
  • General anesthesia for generator placement
  • No particular anesthetic
  • Propofol or inhaled agent work well
  • Avoid dopamine antagonists
  • Avoid demerol
  • Muscle relaxants OK
  • Prevent or treat emergence hypertension
  • Not much pain in post-op setting

25
PD Specific Issues
  • Risk of exacerbation
  • Consider intraoperative continuation of
    medications
  • Hemodynamics may be labile
  • Degeneration of sympathetic ganglia
  • Dopamine-related hypotension, hypovolemia

26
PD Specific Issues
  • Airway or pulmonary compromise
  • Upper airway obstruction
  • Dysarthria and history of choking
  • Restrictive ventilatory pattern
  • Aspiration risk

27
Patients with Existing DBS
  • DBS is usually on 24/7 for PD pts
  • May be off at night in other conditions
  • Consider turning off prior to surgery

28
DBS Surgical Risks
  • Intracerebral hemorrhage
  • Venous air embolism
  • Emotional lability

29
DBS Surgical Risks
  • Intracerebral hemorrhage
  • Monitor patient for neurologic changes
  • Risk 1.6 per lead
  • Avoid hypertension
  • Keep SBP lt 140
  • Consider arterial line
  • Antihypertensives labetalol, hydralazine

30
DBS Surgical Risks
  • Venous air embolism
  • Early detection
  • Communicate with surgeon
  • Support blood pressure
  • Provide O2
  • Airway plan

31
DBS Surgical Risks
  • Emotional Lability
  • Usually no treatment needed
  • Consider sedation PRN

32
DBS Outcomes
  • Bilateral DBS of STN
  • N 49
  • Assessed at 1,3, and 5 years
  • Assessed on and off meds and stimulation
  • (Krack, et al, NEJM 349, 2003)

33
DBS Outcomes
  • Stimulation alone significant improvement
  • Synergy between meds and stimulation
  • Allows decrease in medication doses
  • Improvement in L-dopa dyskinesias
  • Akinesia, speech, and freezing of gait all
    worsened
  • (Krack, et al, NEJM 349, 2003)

34
DBS vs Medical Therapy
  • Randomized-pair trial
  • DBS optimized medical tx
  • Optimized medical tx
  • 75 of pairs favored DBS meds
  • Quality of life
  • Severity of motor sxs off medication
  • (Deuschl et al, NEJM, 355, 2006)

35
DBS other motor diseases
  • Essential tremor
  • Dystonia
  • More sedation during MRI

36
DBS and Tourettes
  • Motor/speech tics
  • Up to 1 school age children
  • 1/3 persist into adulthood

37
DBS for Tourettes(Visser-Vandewalle, J.
Neurosurg 99 2003)
38
DBS and Psychiatric Disease
  • Depression
  • Pilot in 2005
  • 4/6 patients improved gt50 on testing
  • Currently at least 3 ongoing NIH trials
  • 10 to 20 patients per study

39
  • Vagus Nerve Stimulation

40
Vagus Mixed Sensory and Motor
  • 20 efferent parasympathetic control of the
    heart and gut viscera
  • 80 afferent extensive connections to limbic and
    higher cortical systems
  • Animal studies VNS EEG changes and seizure
    cessation

41
Vagal Nerve Stimulation
  • Approved device made by Cyberonics
  • Chronic, intermittent stimulation to cervical
    vagus
  • Prevents and aborts seizures

42
(No Transcript)
43
Vagal Nerve Stimulation
  • Typical settings
  • Automatic 30 sec stimulation q 5 min
  • Additional manual if pt feels aura, may wave
    wand over generator to activate stimulator

44
Vagal Nerve Stimulation
  • Results from 3 studies
  • Significant decrease in seizures 24-35
  • Controls low-level stimulation
  • Seizure frequency decreased further over time
  • Decreased medication doses

45
VNS Surgery
  • Performed under general anesthesia
  • Leads wrapped around L vagus in neck
  • Only L, and only unilateral
  • Generator placed upper left chest

46
Final Electrode/tether Placement
Anchor Tether
Negative Electrode
Positive Electrode
47
VNS Surgery
  • Possible intraop complications with lead testing
  • Arrhythmias- transient sinus arrest
  • Labile hemodynamics
  • Airway obstruction (vocal cord stimulation)- if
    not intubated

48
VNS Surgery
  • Surgical complications
  • Infection 2.9
  • Hoarseness or temporary vocal cord paralysis
    0.7
  • Hypesthesia or lower left facial paralysis 0.7

49
VNS Surgery Chronic Side Effects
  • Hoarseness
  • Cough
  • Paresthesias
  • Dyspepsia
  • Disrupted sleep
  • Worsening sleep apnea

50
VNS Anesthesia
  • Pre-op considerations
  • Take usual seizure medications
  • CBC, electrolytes
  • EKG
  • cardiac medications?

51
VNS Anesthesia
  • May use local, MAC, or GA
  • Usually GA- no restriction on agents
  • Endotracheal tube
  • Blood loss is minimal

52
VNS Anesthesia
  • Anti-seizure medications induce hepatic enzymes--
    higher anesthetic doses?
  • Post-op seizures are common- be prepared
  • Incidence of transient vocal cord paralysis

53
Chronic VNS
  • Turn off for other surgery
  • Restart in recovery

54
VNS for Depression
  • Seizure pts with VNS happier over time!
  • N 60 pts
  • previously failed numerous treatments
  • 2 weeks on meds only
  • 2 weeks stim adjust meds
  • 8 weeks fixed stimu meds

55
VNS for Depression
  • Open label study
  • 30.5 of patients responded with significant
    decrease in depression rating scale
  • 15 full remission
  • Substantial functional improvement, even in
    non-responders

56
VNS for Depression
  • Placebo controlled study
  • N 225
  • VNS-responding patients 15
  • Placebo-responding patients 10
  • Lower levels of stimulation
  • Much to figure out, although now FDA approved

57
Other ongoing VNS studies
  • Cervical VNS
  • PTSD
  • Panic disorder
  • OCD
  • Rapid-cycling bipolar disorder
  • Bilateral diaphragmatic VNS
  • Morbid obesity

58
Functional Neurosurgery
  • DBS
  • Targets stimulation based on neuroanatomy.
    Tailors stim to the disorder.
  • Invasive.
  • Requires neurosurgery
  • VNS
  • Simultaneous stimulation of multiple tracts
    nuclei.
  • No specific target. Same stimulation for a number
    of disorders.
  • Much less invasive. Does not require
    neurosurgeon.
  • Procedure in search of an application?
Write a Comment
User Comments (0)
About PowerShow.com